Cidel Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Cidel Asset Management's GILD Position: Q2 2026 in Review
Cidel Asset Management increased its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, buying an estimated $23.7K and bringing the position to 8,666 shares worth $1.09M. The position accounts for 0.05% of the portfolio, ranked #161.
Cidel Asset Management first reported a position in GILD in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.18M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Cidel Asset Management held 8,666 shares of Gilead Sciences worth $1.09M as of Q2 2026.
- Cidel Asset Management bought 180 Gilead Sciences shares in Q2 2026, an estimated $23.7K.
- Gilead Sciences made up 0.05% of Cidel Asset Management's portfolio in Q2 2026, its #161 holding.
- Cidel Asset Management first reported a position in Gilead Sciences in Q2 2020 and has held it in 18 quarters since.
- Cidel Asset Management's Gilead Sciences position peaked at $1.18M in Q1 2026.
- 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.